Peter Kelley
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 4
- COVID-19 Clinical Research Studies 1
-
- Antibiotic Use and Resistance 3
- Co-authors
- Benjamin P. Howden (4 shared papers)Wei Gao (2 shared papers)Peter B. Ward (1 shared paper)David Gordon (3 shared papers)Peter D. Cooper (1 shared paper)Susanne Heinzel (1 shared paper)Nikolai Petrovsky (1 shared paper)Elizabeth A. Grabsch (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (4 papers)Diagnostic Microbiology and Infectious Disease (2 papers)Pathology (2 papers)The Medical Journal of Australia (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- Australia
In The Last Decade
Peter Kelley
20 papers receiving 414 citations
Peers
Comparison fields: 5 of 55
- Applied Microbiology and Biotechnology 32
- Infectious Diseases 179
- Microbiology 7
- Clinical Biochemistry 21
- Molecular Medicine 22
Countries citing papers authored by Peter Kelley
This map shows the geographic impact of Peter Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kelley more than expected).
Fields of papers citing papers by Peter Kelley
This network shows the impact of papers produced by Peter Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kelley. The network helps show where Peter Kelley may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 87 | |
| 2 | 2011 | 84 | |
| 3 | 2009 | 39 | |
| 4 | 2017 | 38 | |
| 5 | 2016 | 34 | |
| 6 | 2021 | 29 | |
| 7 | 2001 | 28 | |
| 8 | 2018 | 24 | |
| 9 | 2011 | 21 | |
| 10 | 2025 | 9 | |
| 11 | 2023 | 7 | |
| 12 | 2022 | 6 | |
| 13 | 2007 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2014 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2007 | 3 | |
| 18 | 2019 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2022 | 1 |
About Peter Kelley
Peter Kelley is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology, Microbiology and Clinical Biochemistry, having authored 20 papers that have together received 430 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (4 papers), Antibiotic Use and Resistance (3 papers), Nail Diseases and Treatments (2 papers), Mycobacterium research and diagnosis (2 papers), Cytomegalovirus and herpesvirus research (1 paper), COVID-19 Clinical Research Studies (1 paper), Bacterial Identification and Susceptibility Testing (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (32 citations), Infectious Diseases (179 citations), Microbiology (7 citations), Clinical Biochemistry (21 citations) and Molecular Medicine (22 citations). Peter Kelley has collaborated with scholars based in Australia. Frequent co-authors include Benjamin P. Howden, Wei Gao, Peter B. Ward, David Gordon, Peter D. Cooper, Susanne Heinzel, Nikolai Petrovsky, Elizabeth A. Grabsch, M. Lindsay Grayson and Emma Jane Bishop. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Diagnostic Microbiology and Infectious Disease, Pathology, The Medical Journal of Australia and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.